BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

iVOW, Inc. (IVOW) Completes Acquisition Of Sound Health Solutions


11/2/2005 11:05:42 AM

CARLSBAD, Calif., Nov. 2 /PRNewswire-FirstCall/ -- iVOW, Inc. , today announced that it has completed its acquisition of Sound Health Solutions (SHS), a Seattle-based healthcare provider specializing in the multidisciplinary medical treatment of obesity. SHS will operate as a wholly owned subsidiary of iVOW.

"We are very pleased to complete our acquisition of SHS and move forward with our integration plans," said Dr. Michael Owens, President and CEO of iVOW. "The addition of SHS' multidisciplinary clinical model to our bariatric surgical Center of Excellence programmatic approach solidifies the foundation for our chronic and morbid obesity disease management services and products. We are excited about the opportunities for expanding the marketing efforts for SHS' proven medical treatment model, as well as offering hospitals, payors and employers a comprehensive program that includes robust medical and surgical treatment options."

iVOW

Our business is focused exclusively on the disease state management of chronic and morbid obesity. We provide program management, operational consulting and clinical training services to physicians and hospitals involved in the medical and surgical treatment of morbidly obese patients. We also provide specialized vitamins to patients who have undergone obesity surgery. Our corporate website is www.ivow.com; information on our nutritional supplements for post-surgical gastric bypass patients may be found on www.vistavitamins.com. iVOW is the new corporate name of Vista Medical Technologies, Inc. iVOW is traded on the Nasdaq SmallCap Market under the stock symbol IVOWD.

Forward Looking Statements

This news release may contain forward-looking statements concerning the business and products of iVOW. Actual results may differ materially depending on a number of risk factors, including, but not limited to the following: the successful integration of the SHS business; our ability to penetrate the market for obesity surgery management services; customer acceptance of our products and services; decisions by Medicare and carriers to provide coverage for bariatric surgical procedures; uncertainties related to our healthcare services business model; and our efforts to maintain compliance with the continued listing requirements of the Nasdaq SmallCap Market. Other risks inherent in our business are described in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the year ended December 31, 2004, as amended, and our most recent quarterly report on form 10-Q. We undertake no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

AT iVOW: Michael H. Owens, MD, MPH, FACPE, CPE President & CEO mowens@ivow.com (760) 603-9120 AT FINANCIAL RELATIONS BOARD: Media Contact Tony Rossi trossi@financialrelationsboard.com (310) 854-8317

iVOW, Inc.

CONTACT: Michael H. Owens, MD, MPH, FACPE, CPE, President & CEO of iVOW,Inc., +1-760-603-9120, mowens@ivow.com; or Tony Rossi of FinancialRelations Board, +1-310-854-8317, trossi@financialrelationsboard.com, foriVOW, Inc.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->